The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
https://www.neurology.org/podcast
April 15 2008 Issue
This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Peter Goadsby and Dr. Stephen Silberstein interview Dr. Tony Ho from Merck & Co., Inc. about his paper on oral CGRP antagonist, MK-0974, in acute treatment of migraine. The podcast concludes with Dr. Myla Goldman interviewing Dr. Bruce Levin for Lesson of the Week. The participants had nothing to disclose except for Dr. Silberstein. His Author Disclosure is as follows: Income for speaking, consulting or serving on an advisory board- GlaxoSmithKline, Allergan, AstraZeneca, Endo, Medtronic, Merck, J&J, Pfizer, Pozen, Valeant Pharmaceuticals International (not in excess of $10,000) & Research Support- Allergan (not in excess of $10,000).